Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-045693
Filing Date
2024-11-07
Accepted
2024-11-07 17:00:45
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20034474_10q.htm   iXBRL 10-Q 2047838
2 EXHIBIT 31.1 ef20034474_ex31-1.htm EX-31.1 12004
3 EXHIBIT 31.2 ef20034474_ex31-2.htm EX-31.2 11972
4 EXHIBIT 32.1 ef20034474_ex32-1.htm EX-32.1 4613
5 EXHIBIT 32.2 ef20034474_ex32-2.htm EX-32.2 4694
  Complete submission text file 0001140361-24-045693.txt   9284422

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adma-20240930.xsd EX-101.SCH 56091
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adma-20240930_cal.xml EX-101.CAL 54494
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adma-20240930_def.xml EX-101.DEF 280117
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20240930_lab.xml EX-101.LAB 728042
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20240930_pre.xml EX-101.PRE 438241
79 EXTRACTED XBRL INSTANCE DOCUMENT ef20034474_10q_htm.xml XML 1668121
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36728 | Film No.: 241436890
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)